Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc

Bullboard Posts

Comment by OPTSALESon Nov 28, 2012 11:33am

111 Views

Post# 20654738

RE: RE: value of company ??? with FDA approval

I hope you're correct. I find it hard to believe they maybe on to something so big. Then again, even if it alleviates 80% of the symptom’s that is still a new milestone to this drug therapy.

Could hit multiples just with that

of course could hit .20 cts again too should it fail

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property